BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  OvaScience Reports Third Quarter 2017 Financial Results

  As of September 30, 2017, OvaScience had cash, cash equivalents and short-term investments of $75.7 million, compared to $114.4 million as of December 31, 2016.

  November 2, 2017

   · 

  10 min read
• Biotech Beach

  Puma Biotechnology Secures $100 Million Term Loan From Silicon Valley Bank and Oxford Finance

  Puma received gross proceeds of $50 million from the first tranche of the credit facility upon closing on October 31 and intends to use the funds for general corporate purposes and to further support NERLYNX commercial initiatives.

  November 2, 2017

   · 

  5 min read
• Bio NC

  TransEnterix to Feature Senhance Surgical System at AAGL: Advancing Minimally Invasive Gynecology Worldwide

  The congress will be held November 12-16, 2017 in the Washington, DC area at the Gaylord National Resort and Convention Center at National Harbor.

  November 2, 2017

   · 

  3 min read
• Business

  Bio-Rad Reports Third-Quarter 2017 Financial Results

  Third-quarter 2017 net sales were $535.0 million, an increase of 5.2 percent compared to $508.7 million reported for the third quarter of 2016.

  November 2, 2017

   · 

  11 min read
• Business

  Evonik and Lilly Renew Long-Term Supply Agreement

  Evonik Industries and Eli Lilly and Company (Lilly) today announced the renewal of a long-term agreement under which Evonik will supply active pharmaceutical ingredients (APIs) and intermediates for use in key Lilly human and veterinary drug products.

  November 2, 2017

   · 

  3 min read
• Drug Development

  Dimerix Presents Detailed Subgroup Analysis From DMX-200 Phase IIa Trial in Chronic Kidney Disease Showing Compelling Efficacy Signals in Diabetic Nephropathy Patients

  Five of the 6 patient responder sub-group (83%) had a primary diagnosis of diabetic nephropathy and 1 of the 6 responders (17%) had a primary diagnosis of IgA nephropathy.

  November 2, 2017

   · 

  6 min read
• 

  Business

  Biogen Poaches Merck Exec to Lead New Marketing Team

  Mr. Guindo brings 27 years of experience in the global pharma industry and has held several leadership positions at Merck.

  November 2, 2017

   · 

  4 min read
• Biotech Beach

  Human Factors Research Presented at DTM 2017 Demonstrates Ease of Use and Effectiveness of Computer-Based Training for Touchscreen Insulin Pump With Automated Insulin Delivery Feature

  The study demonstrated a 99 percent success rate among study participants who performed a series of critical tasks using the PLGS system after initial training.

  November 2, 2017

   · 

  4 min read
• Business

  Invacare Announces Departure of Chief Financial Officer

  Invacare today announced the resignation of Sr. VP and CFO Robert K. Gudbranson, who will be leaving the company to pursue a new opportunity, effective November 26, 2017

  November 2, 2017

   · 

  4 min read
• Business

  IntelGenx to Report Third Quarter 2017 Financial Results on November 9, 2017 - Conference Call to Follow

  An accompanying conference call will be hosted by Dr. Horst G. Zerbe, President and Chief Executive Officer, and Mr. Andre Godin, Executive Vice-President and Chief Financial Officer, to discuss the results and provide a business update.

  November 2, 2017

   · 

  1 min read